Apremilast for Atopic Dermatitis - A Pilot Study in Adults

Summary

The purpose of this study is to obtain preliminary data regarding the safety and tolerability of apremilast in AD to support the design of larger controlled studies.

Timeline

Start

2009-05

Primary completion

2011-07

Completion

2011-07

Publications

• Samrao A, Berry TM, Goreshi R, Simpson EL. A pilot study of an oral phosphodiesterase inhibitor (apremilast) for atopic dermatitis in adults. Arch Dermatol. 2012 Aug;148(8):890-7. doi: 10.1001/archdermatol.2012.812.

Drugs

Indications